Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 22 of 22 entries
View as:

A Study to Compare Two Bioanalytical Assays for Tebipenem

Phase: N/A Priority: Normal
NCT ID: NCT05856747 Org: User:
Start: 05/04/23 End: 06/01/23 Due: 06/01/24

Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04710407 Org: User:
Start: 12/07/20 End: 03/10/21 Due: 03/10/22

Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04865393 Org: User:
Start: 06/08/21 End: 12/06/21 Due: 12/06/22

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR206 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03792308 Org: User:
Start: 12/18/18 End: 12/23/19 Due: 12/23/20

A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT05955586 Org: User:
Start: 08/01/23 End: 02/23/24 Due: 02/23/25

A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06727136 Org: User:
Start: 11/20/24 End: 04/22/25 Due: 04/22/26

Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04421885 Org: User:
Start: 06/01/20 End: 07/29/20 Due: 07/29/21

Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04868292 Org: User:
Start: 06/03/21 End: 09/29/21 Due: 09/29/22

A Study of the Safety, Tolerability, and Pharmacokinetics of SPR720 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03796910 Org: User:
Start: 12/18/18 End: 09/24/19 Due: 09/24/20

Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT04178577 Org: User:
Start: 12/06/19 End: 09/11/20 Due: 09/11/21

Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Phase: N/A Priority: Normal
NCT ID: NCT03788967 Org: User:
Start: 06/03/19 End: 05/27/20 Due: 05/27/21

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT05496374 Org: User:
Start: 12/14/22 End: 12/02/24 Due: 12/02/25

Effect of Tebipenem on Normal Human Intestinal Microbiota

Phase: N/A Priority: Normal
NCT ID: NCT04376554 Org: User:
Start: 02/10/20 End: 04/06/21 Due: 04/06/22

Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994

Phase: N/A Priority: Normal
NCT ID: NCT03395249 Org: User:
Start: 10/20/17 End: 08/02/18 Due: 08/02/19

Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04625855 Org: User:
Start: 09/30/20 End: 10/16/20 Due: 10/16/21

A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05966688 Org: User:
Start: 08/04/23 End: 02/04/24 Due: 02/04/25

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of SPR741 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03022175 Org: User:
Start: 12/31/16 End: 09/30/17 Due: 09/30/18

Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

Phase: N/A Priority: Normal
NCT ID: NCT03376529 Org: User:
Start: 11/10/17 End: 12/20/17 Due: 12/20/18

Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04368585 Org: User:
Start: 07/01/20 End: 08/21/20 Due: 08/21/21

Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT04553406 Org: User:
Start: 12/03/20 End: 01/28/21 Due: 01/28/22

A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04238195 Org: User:
Start: 01/19/20 End: 02/26/20 Due: 02/26/21

A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Phase: N/A Priority: Normal
NCT ID: NCT06059846 Org: User:
Start: 12/21/23 End: 11/30/25 Due: 11/30/26